Ikeda Saccharification Industry
VC Fund
Hiroshima-shi, Japan
Ikeda Saccharification Industry is a VC fund in Hiroshima-shi focused on Energy and Medical. Ikeda Saccharification Industry is manufacturing caramel, natural colorants, seasonings, dessert foods, sweets, various other food processing, food materials. Drying equipment to produce dried products with the optimum equipment that can make the use of the product characteristics and the characteristics of the material, and the processingconditions by manufacturing tests. Raw materials are mixed uniformly and heated, cooled, and cooked.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ikeda Saccharification Industry invests in
Stages Ikeda Saccharification Industry invests in
Countries Ikeda Saccharification Industry invests in
Investment Focus
Industry
- Energy 1 (50%)
- Medical 1 (50%)
- Agriculture 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
Stage
- Funding Round 1 (50%)
- Venture - Series Unknown 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Chitose Group
|
CHITOSE GROUP is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. CHITOSE GROUP is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technologicaldevelopment capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology”. | $28.6M / Venture - Series Unknown / Mar 10, 2025 | |
|
Chitose Group
|
CHITOSE GROUP is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. CHITOSE GROUP is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technologicaldevelopment capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology”. | $22.5M / Venture - Series Unknown / Jul 13, 2023 |
Co-Investors
Amano Enzyme
2 deals together
Mers Line
2 deals together
Mitsui Mining & Smelting
2 deals together
NGK Insulators
2 deals together
Shinsho
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ikeda Saccharification Industry invest in?
Ikeda Saccharification Industry invests primarily in Energy, Medical and Agriculture startups, most often at Funding Round and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ikeda Saccharification Industry last invest?
The most recent investment recorded for Ikeda Saccharification Industry closed in Mar 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
